Llwytho...
Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study
AIM: To evaluate (I) trastuzumab-containing primary systemic therapy (PST) in human epidermal growth factor receptor 2 (Her2) overexpressing breast carcinomas; (II) compare the patients who achieved and those who did not achieve pathological complete remission (pCR), and (III) analyze the accuracy o...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Croat Med J |
|---|---|
| Prif Awduron: | , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Croatian Medical Schools
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4410165/ https://ncbi.nlm.nih.gov/pubmed/25891872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2015.56.128 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|